Hepatitis B

Disease

Also known as: HBV

Disease Profile

Hepatitis B is a viral liver infection caused by the hepatitis B virus that can present as acute or chronic disease. Chronic infection can lead to cirrhosis, liver failure, and hepatocellular carcinoma. Transmission occurs through blood and body fluids, including perinatal, sexual, and parenteral routes.

Category
Viral infectious liver disease
Prevalence
WHO estimated 254 million people were living with chronic hepatitis B infection in 2022
ICD Codes
  • B18.1

Related News

Experts Warn Hepatitis B Treatment Too Complex; Philippines Faces High Burden

In the Philippines, an estimated 7.3 million adults live with chronic hepatitis B, far above regional averages. Experts warn that complex treatment guidelines may hinder front-line clinicians from initiating care, while Thailand’s success with vaccination shows a path to elimination. Expanding screening and simplifying treatment are critical steps.

Related Clinical Trials

NCT ID Title Status Phase
NCT07637214

A Real-world Study: Analysis of the Efficacy of Antiviral Therapy in CHB Patients Over 30 Years Old, HBV DNA Positive and ALT Normal

COMPLETED
NCT07589985

Hep Mec Cohort in Zambia

RECRUITING
NCT07253220

TAF Monotherapy Versus ETV Combined With TAF on the Efficacy and Prognosis of Immunotherapy for Hepatitis B-Related Hepatocellular Carcinoma

NOT_YET_RECRUITING NA
NCT07168356

A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease

ACTIVE_NOT_RECRUITING PHASE1
NCT07154212

Hepatitis B Virus Reactivation in COVID-19

COMPLETED
NCT07126041

Scalable Public Health Empowerment, Research, and Education Sites (SPHERES)

NOT_YET_RECRUITING NA
NCT07085715

Pan-Viral Screening and Linkage to Care Among GBMSM and Trans Women in Spain

NOT_YET_RECRUITING
NCT07079150

Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

RECRUITING
NCT06998992

Assessing the Reliability of Self-Reported Hepatitis B Vaccination Status in Outpatients: Evaluation of Individuals Born in France and Consulting at the CeGIDD in Saint-Denis.

COMPLETED
NCT06947499

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

RECRUITING PHASE2/PHASE3